California biotech Apexigen has raised $73 million from a pair of financings that will be used for clinical testing of its lead CD40-targeting immuno-oncology candidate as well as to broaden its pipeline.
The CEO and CMO of Adverum Biotechnologies have left the gene therapy startup. Adverum said Amber Salzman, Ph.D., stepped down as CEO and president by “mutual determination,” while CMO Athena Countouriotis, M.D., resigned after less than one year in the j